415P Patterns of Time-to-progression Intervals Across Clinical and Liquid Biopsy (LB) Features in Hormone Receptor-Positive (HR+) HER2-negative (HER2-) Metastatic Breast Cancer (MBC) Patients (pts) Treated with First-Line Endocrine Therapy (ET)
Annals of Oncology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined